بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
reduction decrease » reduction decreased (توسيع البحث), reduction reuse (توسيع البحث), production increases (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
reduction decrease » reduction decreased (توسيع البحث), reduction reuse (توسيع البحث), production increases (توسيع البحث)
-
1321
Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.
منشور في 2024"…<p>Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…"
-
1322
-
1323
Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database.
منشور في 2025الموضوعات: -
1324
-
1325
<b>Nest mass in forest tits </b><b><i>Paridae</i></b><b> </b><b>increases with elevation and decreasing body mass, promoting reproductive success</b>
منشور في 2025"…We found that nest mass increased by ~ 60% along the elevational gradient, but the effect of canopy openness on nest mass was not significant, while nest mass decreased along the ranked species from the smallest <i>Periparus ater</i> to the medium-sized <i>Cyanistes caeruleus</i> and the largest <i>Parus major</i>. …"
-
1326
-
1327
-
1328
-
1329
Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration:
منشور في 2025"…Administration of cisplatin (2.5 mg/Kg) and vitamin D3 (125 µg/Kg) significantly decreased the vessel density (CD31) compared to the tumor control group.…"
-
1330
-
1331
-
1332
-
1333
-
1334
-
1335
-
1336
-
1337
-
1338
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
1339
-
1340
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: